The Food and Drug Administration today released for comment draft guidance clarifying what types of clinical and patient decision support software would no longer be regulated by the agency as a medical device under the 21st Century Cures Act. FDA Commissioner Scott Gottlieb, M.D., said the guidance generally excludes from regulation software that allows a health care provider or patient to independently review the basis for its treatment recommendations. In addition, FDA released draft guidance clarifying that certain digital health technologies, such as mobile apps intended solely to maintain or encourage a healthy lifestyle, generally fall outside the scope of FDA regulation under the Act, and final guidance adopting international principles for harmonizing the regulation of software with a medical purpose.

Related News Articles

Headline
The White House Office of Science and Technology Policy Friday released an updated national plan for federal investment in artificial intelligence research and…
Blog
In this AHA Stat Blog, Jay Bhatt, D.O., senior vice president and chief medical officer of the AHA, and Elisa Arespacochaga, vice president of the AHA…
Headline
The AHA today submitted comments on the revised version of the Lower Health Care Costs Act (S. 1895), legislation to prevent surprise medical bills, reduce…
Headline
The Senate Committee on Health, Education, Labor and Pensions today held a hearing on the Lower Health Care Costs Act, its draft legislation to prevent…
Headline
The AHA said it is generally supportive of the overall concept of the agreement and agency’s goal to create a voluntary network-of-networks that would enable…
Headline
AHA's Physician Alliance will host a webinar on how artificial intelligence technology is being used to optimize practice and reduce clinician burden